Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
237
-
Total shares
-
63.9M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$5.86B
-
Value change
-
+$156M
-
Put/Call ratio
-
1.53
-
Number of buys
-
102
-
Number of sells
-
-130
-
Price
-
$91.82
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q3 2019
256 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q3 2019.
BLUEBIRD BIO INC - COM (BLUE) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
.
Largest 10 shareholders include FMR LLC (7.81M shares), WELLINGTON MANAGEMENT GROUP LLP (7.48M shares), Capital Research Global Investors (6.77M shares), Capital International Investors (5.44M shares), Capital World Investors (5.2M shares), VANGUARD GROUP INC (3.78M shares), BAILLIE GIFFORD & CO (3.46M shares), BlackRock Inc. (2.93M shares), SANDS CAPITAL MANAGEMENT, LLC (2.18M shares), and VICTORY CAPITAL MANAGEMENT INC (1.71M shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.